UP-TO-DATE, RESEARCH BASED INFORMATION ABOUT PSYCHEDELICS.
European Union funds groundbreaking research into psychedelic therapy
A European consortium of 19 partners has been awarded €6,5 million by the European Union’s Horizon Europe programme to study psilocybin to treat psychological distress in people with progressive incurable illnesses requiring palliative care.
Applying key lessons from the hospice and palliative care movement to inform psychedelic-assisted therapy
The intention of this commentary is to articulate the deep synergies between hospice and palliative care and PAT.
Psilocybin mushrooms for psychological and existential distress: Treatment for a patient with palliative lung cancer
This experience led to immediate, substantial, and sustained improvements in her distress and quality of life.
The therapeutic potential of psychedelic-assisted therapies for symptom control in patients diagnosed with serious illness: A systematic review
The evaluated evidence suggests positive effects of psychedelic-assisted therapies for symptom control in patients diagnosed with serious illness.
The therapeutic potential of psychedelic substances in hospice and palliative care
Development of meaning-creating psychotherapies and further research findings in psychedelic therapies may contribute to more compassionate and mindful care.
YouGov results - Is the UK ready to reschedule psilocybin?
UK survey on attitudes to psilocybin